Journey Medical Corp Stock Analysis

DERM Stock  USD 5.57  0.20  3.72%   
Journey Medical Corp is fairly valued with Real Value of 5.39 and Target Price of 6.5. The main objective of Journey Medical stock analysis is to determine its intrinsic value, which is an estimate of what Journey Medical Corp is worth, separate from its market price. There are two main types of Journey Medical's stock analysis: fundamental analysis and technical analysis.
The Journey Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Journey Medical is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day. Journey Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Journey Stock Analysis Notes

About 32.0% of the company shares are held by company insiders. The book value of Journey Medical was currently reported as 0.65. The company recorded a loss per share of 0.17. Journey Medical Corp had not issued any dividends in recent years. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 90 people. To learn more about Journey Medical Corp call the company at 480 434 6670 or check out

Journey Medical Quarterly Total Revenue

13.03 Million

Journey Medical Corp Investment Alerts

Journey Medical Corp is way too risky over 90 days horizon
Journey Medical Corp appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 79.18 M. Net Loss for the year was (3.85 M) with profit before overhead, payroll, taxes, and interest of 42.89 M.
About 32.0% of the company shares are held by company insiders
Latest headline from Public companies are Journey Medical Corporations biggest owners and were rewarded after market cap rose by US26m last week

Journey Medical Corp Upcoming and Recent Events

3rd of April 2024
Upcoming Quarterly Report
27th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
3rd of April 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Journey Largest EPS Surprises

Earnings surprises can significantly impact Journey Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Journey Medical Environmental, Social, and Governance (ESG) Scores

Journey Medical's ESG score is a quantitative measure that evaluates Journey Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Journey Medical's operations that may have significant financial implications and affect Journey Medical's stock price as well as guide investors towards more socially responsible investments.

Journey Stock Institutional Investors

Heron Bay Capital Management2024-03-31
33.7 K
Jane Street Group, Llc2023-12-31
27.7 K
State Street Corporation2024-03-31
25.6 K
Brighton Jones Llc2024-03-31
23 K
Bank Of America Corp2024-03-31
22.7 K
Perkins Capital Management Inc2024-03-31
22 K
Goldman Sachs Group Inc2024-03-31
20 K
Northern Trust Corp2024-03-31
17.7 K
Springbok Capital Management, Llc2024-03-31
15.1 K
Vanguard Group Inc2024-03-31
310.2 K
Renaissance Technologies Corp2024-03-31
270.6 K
Note, although Journey Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Journey Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 111.47 M.

Journey Profitablity

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.77.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.07)(0.07)
Return On Capital Employed 0.03  0.03 
Return On Assets(0.05)(0.05)
Return On Equity(0.19)(0.18)

Management Efficiency

As of the 18th of June 2024, Return On Capital Employed is likely to grow to 0.03, while Return On Tangible Assets are likely to drop (0.07). At this time, Journey Medical's Intangible Assets are very stable compared to the past year. As of the 18th of June 2024, Intangibles To Total Assets is likely to grow to 0.28, while Non Current Assets Total are likely to drop about 16.4 M. Journey Medical's management efficiency ratios could be used to measure how well Journey Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 1.12  1.06 
Enterprise Value Over EBITDA 19.35  20.32 
Price Book Value Ratio 5.16  3.50 
Enterprise Value Multiple 19.35  20.32 
Price Fair Value 5.16  3.50 
Enterprise Value95.3 M105.4 M
The analysis of Journey Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Journey Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Journey Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
Profit Margin
Return On Assets
Return On Equity

Technical Drivers

As of the 18th of June 2024, Journey Medical retains the Market Risk Adjusted Performance of (0.70), downside deviation of 6.67, and Risk Adjusted Performance of 0.0899. Journey Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Journey Medical Corp variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Journey Medical is priced fairly, providing market reflects its last-minute price of 5.57 per share. Given that Journey Medical Corp has jensen alpha of 0.8785, we strongly advise you to confirm Journey Medical Corp's regular market performance to make sure the company can sustain itself at a future point.

Journey Medical Corp Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Journey Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Journey Medical Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Journey Medical Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Journey Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Journey Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Journey Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Journey Medical Predictive Daily Indicators

Journey Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Journey Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Journey Medical Corporate Filings

31st of May 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
14th of May 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
13th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
1st of May 2024
Report filed with the SEC to announce major events that shareholders should know about
29th of April 2024
Other Reports
29th of March 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
27th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
25th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities

Journey Medical Forecast Models

Journey Medical's time-series forecasting models are one of many Journey Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Journey Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Journey Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Journey Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Journey shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Journey Medical. By using and applying Journey Stock analysis, traders can create a robust methodology for identifying Journey entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.05)(0.05)
Operating Profit Margin 0.01  0.01 
Net Loss(0.05)(0.05)
Gross Profit Margin 0.66  0.75 

Current Journey Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Journey analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Journey analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.5Strong Buy2Odds
Journey Medical Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Journey analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Journey stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Journey Medical Corp, talking to its executives and customers, or listening to Journey conference calls.
Journey Analyst Advice Details

Journey Stock Analysis Indicators

Journey Medical Corp stock analysis indicators help investors evaluate how Journey Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Journey Medical shares will generate the highest return on investment. By understating and applying Journey Medical stock analysis, traders can identify Journey Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow32 M
Long Term Debt14.6 M
Common Stock Shares Outstanding18.2 M
Total Stockholder Equity20.4 M
Tax Provision108 K
Property Plant And Equipment Net101 K
Cash And Short Term Investments27.4 M
Cash27.4 M
Accounts Payable18.3 M
Net Debt-9.7 M
50 Day M A3.9462
Total Current Liabilities41.9 M
Other Operating Expenses78.1 M
Non Current Assets Total20.4 M
Non Currrent Assets Other6000.00
Stock Based Compensation2.6 M

Additional Information and Resources on Investing in Journey Stock

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.